Loretta Itri
Directeur Technique/Scientifique/R&D chez AADI BIOSCIENCE, INC.
Fortune : 5 040 $ au 30/04/2024
Provenance du réseau au premier degré de Loretta Itri
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 34 | |
| Public Company | Biotechnology | 19 | |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ.
18
| Extinct | Pharmaceuticals: Major | 18 |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Loretta Itri via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director of Finance/CFO Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Sales & Marketing Chief Executive Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Undergraduate Degree | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | President Director/Board Member Corporate Officer/Principal Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chairman | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
| ORASURE TECHNOLOGIES, INC. | Medical Specialties | Chairman Chairman | |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| The University of Texas at Austin | College/University | Undergraduate Degree Doctorate Degree | |
| Pace University | College/University | Masters Business Admin Undergraduate Degree | |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Administrative Officer General Counsel | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Fairleigh Dickinson University | College/University | Undergraduate Degree Masters Business Admin | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| Texas A&M University | College/University | Graduate Degree Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistiques
Internationale
| Etats-Unis | 48 |
| France | 2 |
| Irlande | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 37 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 293 |
| Corporate Officer/Principal | 169 |
| Independent Dir/Board Member | 90 |
| Undergraduate Degree | 55 |
| Chairman | 53 |
Relations les plus connectées
| Insiders | |
|---|---|
| Fred Eshelman | 34 |
| Douglas G. Watson | 30 |
| William W. Crouse | 29 |
| Richard Maroun | 27 |
| Alexander Denner | 25 |
| Robert Hugin | 24 |
| Caley Castelein | 23 |
| Adam Sharkawy | 21 |
| Karin Hehenberger | 21 |
| Sarah Schlesinger | 19 |
| Robert G. Savage | 19 |
| Anupam Dalal | 18 |
| Paris Panayiotopoulos | 18 |
| Emma Reeve | 18 |
| Martin Driscoll | 16 |
- Bourse
- Insiders
- Loretta Itri
- Connexions Sociétés
